ES2061794T3 - Nuevos derivados de benzazepina. - Google Patents

Nuevos derivados de benzazepina.

Info

Publication number
ES2061794T3
ES2061794T3 ES89110490T ES89110490T ES2061794T3 ES 2061794 T3 ES2061794 T3 ES 2061794T3 ES 89110490 T ES89110490 T ES 89110490T ES 89110490 T ES89110490 T ES 89110490T ES 2061794 T3 ES2061794 T3 ES 2061794T3
Authority
ES
Spain
Prior art keywords
link
benzazepina
new derivatives
halogen
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89110490T
Other languages
English (en)
Inventor
Louis Brammer Hansen
Frederik Gronvald
Peter Hongaard Andersen
Peter Faarup
Erling Guddal
Kristian Tage Hansen
Erik B Nielsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Application granted granted Critical
Publication of ES2061794T3 publication Critical patent/ES2061794T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

NUEVAS BENZOACEPINAS 2,3,4,5-TETRAHIDRO-1H-3 TENIENDO LA FORMULA: EN DONDE R3 REPRESENTA H,C1-3-ALQUIL O C3-7-CICLOALQUIL; R4 REPRESENTA HIDROGENO O R4 JUNTO CON R10 REPRESENTA UN ENLACE EL CUAL CONECTA LAS POSICIONES A LAS CUALES ESTAN UNIDOS R4 Y R10, SIENDO DICHO ENLACE -CH2-CH2-, -CH=CH-, -O-CH2-O-S-CH2-; R7 REPRESENTA HIDROXILO O ALCOXILO INFERIOR; R10,R11,R12 REPRESENTAN INDEPENDIENTEMENTE HIDROGENO O HALOGENO O ALQUILO O R10 JUNTO CON R4 REPRESENTA UN ENLACE COMO EL DESCRITO EN CONEXION CON LA DEFINICION DE R4; O R10 JUNTO CON R11 REPRESENTA UN ENLACE O R11 JUNTO CON R12 REPRESENTA UN ENLACE, SIENDO EL ENLACE EN AMBOS CASOS ELEGIDO ENTRE -O-CH2-CH2-, -O-CH2-CH2-CH2-, -O-CH=CH-, -CH2-CH2-CH2-, CH2-CH=CH O -CH2-CH2-CH2-CH2-; R13 REPRESENTA HIDROGENO, HALOGENO, O ALQUILO INFERIOR. LOS COMPUESTOS SE USAN EN PREPARADOS PARA TRATAMIENTO DE DESORDENES EN EL SISTEMA NERVIOSO CENTRAL.
ES89110490T 1988-06-15 1989-06-09 Nuevos derivados de benzazepina. Expired - Lifetime ES2061794T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK325188A DK325188D0 (da) 1988-06-15 1988-06-15 Hidtil ukendte benzazepinderivater

Publications (1)

Publication Number Publication Date
ES2061794T3 true ES2061794T3 (es) 1994-12-16

Family

ID=8120790

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89110490T Expired - Lifetime ES2061794T3 (es) 1988-06-15 1989-06-09 Nuevos derivados de benzazepina.

Country Status (15)

Country Link
US (2) US5010074A (es)
EP (1) EP0347672B1 (es)
JP (1) JP2769718B2 (es)
AT (1) ATE102188T1 (es)
AU (1) AU622911B2 (es)
CA (1) CA1317938C (es)
DE (1) DE68913367T2 (es)
DK (1) DK325188D0 (es)
ES (1) ES2061794T3 (es)
FI (1) FI93354C (es)
IE (1) IE891932L (es)
IL (1) IL90533A (es)
NO (1) NO173865C (es)
NZ (1) NZ229521A (es)
PT (1) PT90883B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK67489D0 (da) * 1989-02-14 1989-02-14 Novo Industri As Nye benzazepinderivater
US5158948A (en) * 1990-11-16 1992-10-27 Abbott Laboratories Tetracyclic spirobenzazepine dopamine antagonists
DK23392D0 (da) * 1992-02-24 1992-02-24 Novo Nordisk As Heterocykliske forbindelser, deres anvendelse og fremstilling
US5470850A (en) * 1992-02-24 1995-11-28 Novo Nordisk A/S 2,3,4,5-tetrahydro-1H-3-benzazepines
US6211173B1 (en) 1997-03-12 2001-04-03 Cenes Limited Use of 2,3,4,5-tetrahydro-1H-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders
US6277844B1 (en) 1998-09-14 2001-08-21 Sydney Spector Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis
GB0130576D0 (en) * 2001-12-20 2002-02-06 Cenes Ltd Dopamine D1 receptor agonist pro-drug compounds & derivatives
EP1537115B1 (en) * 2002-08-29 2008-05-28 Schering Corporation Selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders
EP2133340B1 (en) 2002-12-20 2013-01-16 Glaxo Group Limited Novel benzazepine derivatives
CA2526017A1 (en) * 2003-05-22 2005-04-21 Schering Corporation 5-h-benzo[d]naphth[2,1-b]azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA974989A (en) * 1968-03-11 1975-09-23 Wallace And Tiernan Inc. Process for preparing 1,2,4,5-tetrahydro-3h,3-benzazepines and products obtained thereby
US4210749A (en) * 1974-11-12 1980-07-01 Pennwalt Corporation Substituted 1,2,4,5-tetrahydro-3H,3 benzazepines
ZA792042B (en) * 1978-05-08 1980-05-28 Scherico Ltd Substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof and pharmaceutical compositions containing them
US4284556A (en) * 1980-01-31 1981-08-18 Smithkline Corporation 7,8-Amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4327023A (en) * 1980-01-31 1982-04-27 Smithkline Corporation Intermediates for preparing 7,8-amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
DK180485D0 (da) * 1985-04-22 1985-04-23 Novo Industri As Nitrogenholdige forbindelser
KR900007781B1 (ko) * 1986-01-16 1990-10-20 쉐링 코포레이션 융합된 벤즈아제핀
EP0244088A3 (en) * 1986-04-03 1989-03-15 Smithkline Beecham Corporation 1-phenyl-3-benzazepine compounds and medicaments containing these compounds for treating gastrointestinal motility disorders

Also Published As

Publication number Publication date
AU622911B2 (en) 1992-04-30
NO892476L (no) 1989-12-18
IL90533A0 (en) 1990-01-18
FI93354C (fi) 1995-03-27
US5010074A (en) 1991-04-23
IL90533A (en) 1994-05-30
IE891932L (en) 1989-12-15
US5025009A (en) 1991-06-18
DK325188D0 (da) 1988-06-15
JP2769718B2 (ja) 1998-06-25
EP0347672B1 (en) 1994-03-02
ATE102188T1 (de) 1994-03-15
NZ229521A (en) 1991-12-23
EP0347672A1 (en) 1989-12-27
FI93354B (fi) 1994-12-15
DE68913367T2 (de) 1994-06-01
AU3635989A (en) 1989-12-21
NO173865C (no) 1994-02-16
FI892946A0 (fi) 1989-06-15
JPH0240364A (ja) 1990-02-09
FI892946A7 (fi) 1989-12-16
DE68913367D1 (de) 1994-04-07
NO892476D0 (no) 1989-06-14
PT90883B (pt) 1994-12-30
NO173865B (no) 1993-11-08
PT90883A (pt) 1989-12-29
CA1317938C (en) 1993-05-18

Similar Documents

Publication Publication Date Title
CO4700455A1 (es) Derivados tetraciclicos y proceso para su preparacion
ES2064667T3 (es) Derivados de 3-aminopiperidina y heterociclos relacionados que contienen nitrogeno.
ES2101331T3 (es) Derivados de k-252a.
ES2053778T3 (es) Procedimiento para la obtencion de derivados del tiazol.
ES2074867T3 (es) Derivados de quinazolina para potenciar la actividad antitumoral.
DK0412149T3 (da) Anvendelse af IL-7 til tilvejebringelse af lægemidler til stimulering af blodpladeproduktion
MX173140B (es) Derivados aromaticos y heterociclicos de carboxamida, utiles como agentes antitumorales y procedimiento para su preparacion
ATE40365T1 (de) 3-acylaminomethylimidazo (1,2-a> pyridine, dessen herstellung und therapeutische anwendung.
ES2052629T3 (es) Pirazolo(3,4-d)piridinas, procedimiento para su preparacion y utilizacion como medicamentos.
FI893095A7 (fi) Foerfarande foer infoerande och bindande av gas i vatten, anordning foer utfoerande av foerfarandet och vatten som framstaellts med foerfarandet.
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
ES2061794T3 (es) Nuevos derivados de benzazepina.
AR241082A1 (es) Nuevos derivados de pirazol utiles como agentes herbicidas, las composiciones herbicidas que los contienen y los procedimientos para producir estos derivados de pirazol".
FI870633A7 (fi) Tuolin istuin.
FI895447A0 (fi) Substituerade adeninderivat anvaendbara som terapeutiska substanser.
ATE17719T1 (de) Schwefel-substituierte phenoxypyridine mit antiviraler aktivitaet.
ES2075004T3 (es) Derivados de pirimidina, procedimientos para su produccion y composiciones herbicidas que los contienen.
DK0479093T3 (da) Oligosaccharidderivater og deres anvendelse som lægemidler
ES2068714T3 (es) Derivados de pirimidina para aumentar la actividad antitumoral.
ES2153842T3 (es) Derivados de 3-oxo-pirido(1,2-a-)bencimidazol-4-carboxilo y de 4-oxo-azepino(1,2-a)bencimidazol-5-carboxilo utiles en el tratamiento de enfermedades del sistema nervioso central.
ES2181787T3 (es) Derivados de la 3h-2,3-benzodiazepina sustituidos en posicion 3, y su su utilizacion como medicamentos
ES2016464A6 (es) Procedimiento para preparar derivados de 2', 5' -oligoadenilato.
NO883070D0 (no) 4-aminosubstituerte 1,2-dihydroksynaftalin-derivater.
ES2036533T3 (es) Derivados de 1,6-naftiridina, procedimientos para su obtencion y de medicamentos que los contienen para el tratamiento de enfermedades de los vasos sanguineos.
AR023199A1 (es) Solucion acuosa estable de em12, y procedimiento de preparacion de dicha solucion

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 347672

Country of ref document: ES